- Home
- VLY vs PCVX Comparison
VLY vs PCVX Comparison
Compare VLY & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VLY | PCVX |
|---|---|---|
| Founded | 1927 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | VLY | PCVX |
|---|---|---|
| Price | $12.00 | $48.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $13.14 | ★ $105.00 |
| AVG Volume (30 Days) | ★ 5.6M | 1.1M |
| Earning Date | 01-29-2026 | 02-24-2026 |
| Dividend Yield | ★ 3.75% | N/A |
| EPS Growth | ★ 40.78 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $1,704,193,000.00 | N/A |
| Revenue This Year | $33.72 | N/A |
| Revenue Next Year | $10.15 | N/A |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | ★ 8.06 | N/A |
| 52 Week Low | $7.48 | $27.66 |
| 52 Week High | $12.45 | $93.77 |
Technical Indicators
Market Signals| Indicator | VLY | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 58.62 |
| Support Level | $11.60 | $44.57 |
| Resistance Level | $12.45 | $49.55 |
| Average True Range (ATR) | 0.26 | 2.05 |
| MACD | -0.04 | 0.20 |
| Stochastic Oscillator | 50.82 | 75.56 |
Price Performance
Historical ComparisonAbout VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.